Gastrointestinal complications in children with acute myeloid leukemia

Gastrointestinal complications in pediatric acute myeloid leukemia (AML) have not been systematically described in the literature. Our objective was to describe complications related to the small and large bowel in children with AML. Literature searches were conducted of Ovid Medline™ from 1950 to N...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2010-05, Vol.51 (5), p.768-777
Main Authors: Gray, Tyler L. V., Ooi, Chee Y., Tran, Dat, Traubici, Jeffrey, Gerstle, J. Ted, Sung, Lillian
Format: Article
Language:English
Subjects:
acute myeloid leukemia
Child
enteritis
enterocolitis
Gastrointestinal
Gastrointestinal Diseases - etiology
Gastrointestinal Diseases - therapy
Humans
Leukemia, Myeloid, Acute - complications
Leukemia, Myeloid, Acute - therapy
pediatric
Prognosis
typhlitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gastrointestinal complications in pediatric acute myeloid leukemia (AML) have not been systematically described in the literature. Our objective was to describe complications related to the small and large bowel in children with AML. Literature searches were conducted of Ovid Medline™ from 1950 to November 2009 and EMBASE™ from 1980 to November 2009. We included any study design that described gastrointestinal complications in children and/or adults with AML. Common gastrointestinal complications were typhlitis and enterocolitis. Less common complications included appendicitis, pneumatosis intestinalis, and perianal infections. Both leukemia infiltration and intensive chemotherapy likely play a role in the etiology of these conditions. There is a paucity of carefully conducted studies that describe the natural history of typhlitis and enterocolitis and evidence is needed to help guide the management of gastrointestinal complications. Gastrointestinal complications are relatively common in children with AML. Conduction of carefully performed cohort studies is needed to better understand the spectrum of symptoms and expected consequences of gastrointestinal complications. Randomized trials are required to develop evidence-based guidelines for the management of gastrointestinal complications in pediatric AML.
ISSN:1042-8194
1029-2403
DOI:10.3109/10428191003695652